← Evidence map

ArticlePeerJ2025

ALDOB is a prognostic biomarker and a potential immunotherapy target for clear cell renal cell carcinoma.

Wu Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40852386